Page last updated: 2024-10-26

enoxacin and Lung Diseases, Obstructive

enoxacin has been researched along with Lung Diseases, Obstructive in 5 studies

Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.

Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.

Research Excerpts

ExcerptRelevanceReference
" The careful monitoring of serum theophylline level and modification of theophylline dosage in patients receiving enoxacin and theophylline were recommended."1.28[Effect of enoxacin on theophylline pharmacokinetics]. ( Liu, YN, 1992)
"Enoxacin is a safe and effective alternative to parenteral treatment of lower respiratory tract infections."1.27Enoxacin in the treatment of lower respiratory tract infections. ( Arnaud, A; Frances, Y; Nourrit, J; Philip-Joet, F, 1988)
" The patients were divided into 5 groups according with the timing of sampling: 1, 3, 6, 12 hours after dosing at day 3 (group I, II, III, IV), 3 hours after dosing at day 1, 2 and 3 (group V)."1.27[Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man]. ( Benard, Y; Malbruny, B; Morel, C; Vergnaud, M, 1987)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, YN1
Philip-Joet, F1
Nourrit, J1
Frances, Y1
Arnaud, A1
Morel, C1
Vergnaud, M1
Malbruny, B1
Benard, Y1
Wijnands, WJ1
Vree, TB1
Van Herwaarden, CL1

Other Studies

5 other studies available for enoxacin and Lung Diseases, Obstructive

ArticleYear
[Effect of enoxacin on theophylline pharmacokinetics].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 1992, Volume: 15, Issue:2

    Topics: Adult; Aged; Aminophylline; Drug Interactions; Enoxacin; Humans; Lung Diseases, Obstructive; Male; M

1992
Enoxacin in the treatment of lower respiratory tract infections.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 21 Suppl B

    Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Chronic Disease; Drug

1988
[Diffusion, in the bronchial mucus, of enoxacin administered by oral route in man].
    Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2

    Topics: Aged; Diffusion; Enoxacin; Humans; Lung Diseases, Obstructive; Middle Aged; Naphthyridines; Sputum

1987
[Enoxacin and theophylline].
    Infection, 1986, Volume: 14 Suppl 3

    Topics: Drug Interactions; Enoxacin; Humans; Lung Diseases, Obstructive; Naphthyridines; Theophylline

1986
Enoxacin decreases the clearance of theophylline in man.
    British journal of clinical pharmacology, 1985, Volume: 20, Issue:6

    Topics: Adult; Aged; Depression, Chemical; Enoxacin; Female; Humans; Lung Diseases, Obstructive; Male; Middl

1985